Japan merger to create wholesaling behemoth
This article was originally published in Scrip
Executive Summary
Japan's top two pharmaceutical wholesalers are to merge in a stock swap next April 1st to create a giant operation with combined sales of around ¥4,400 billion ($43.8 billion) and offering nationwide coverage for a broad range of prescription and other healthcare products.